-
South Korea invests to resolve difficulties by MPE companies
2023.04.03 -
Competition for developing microneedle-based drugs intensifying
2023.03.28 -
The “inner beauty” craze in the pharmaceutical industry
2023.03.23 -
Korean food companies flocking to the bio market
2023.03.23 -
Daewoong licenses out pulmonary fibrosis drug valued at 336 million USD
2023.03.16 -
All K-bio players gather in Songdo
2023.03.14 -
Chong Kun Dang enters the 'ADC' market
2023.03.10 -
K-bio’s workforce issues
2023.03.09 -
K-bio scramble to get approval for biosimilars
2023.03.03 -
Expectations for world's first multi-target stroke drug
2023.03.02 -
Conglomerates launch with different goals
2023.02.24 -
Korean government to provide financial support for bio R&D
2023.02.22 -
Pharma and bio companies eye on "Pet-fam"
2023.02.20 -
Korea Investment Partners to invest 550 billion won
2023.02.16 -
Market growth for hair care
2023.02.16 -
Big-Pharma & FDA employees flock to K-bio
2023.02.09 -
K-BIO on spotlight during JPM week
2023.02.07 -
Korean government expands tax credits for vaccine developers
2023.02.02 -
The food industry enthralled by bio
2023.02.02 -
LegoChem Biosciences transfers ADC platform tech worth $1.247.5 billion
2023.02.02